CXCL9 and systemic sclerosis: This analysis revealed that there was no significant and meaningful (fold change [FC] > 2) upregulation in the expression of SPP1, CCL4, CCL5, and CXCL9 in systemic sclerosis myeloid cells (Figure 5H).